Cangrelor to Clopidogrel or Prasugrel Transition Study
Status:
Completed
Trial end date:
2014-01-20
Target enrollment:
Participant gender:
Summary
There are two separate objectives in this study:
1. To demonstrate the pharmacodynamic (PD) profile when participants treated with cangrelor
are switched to oral prasugrel 60 mg administered 30 minutes (min) after cangrelor
infusion is discontinued
2. To demonstrate the PD profile when participants treated with cangrelor are switched to
oral clopidogrel 600 mg administered during or immediately after cangrelor infusion.